Skip to main content
. 2019 Aug 30;20(17):4256. doi: 10.3390/ijms20174256
5-LOX 5-lipoxygenase
AD Alzheimer’s disease
ADAS-Cog Alzheimer’s disease assessment scale–cognitive subscale
ADCS Activities of daily living scales
ALA α linolenic acid
ApoE apolipoprotein E
APP amyloid precursor protein
ARA arachidonic acid
amyloid beta peptide
BADLS Bristol’s activities of daily living scale
BASDEC brief assessment schedule depression cards
BBB blood–brain barrier
BDI Beck depression inventory scale
CDR clinical dementia rating scale
CGI clinical global impression scale
CIBIC-Plus clinician interview-based impression of change, plus carer interview
COX cyclooxygenase
cPLA2 cytosolic calcium-dependent phospholipase A2
CSF cerebrospinal fluid
DHA docosahexaenoic acid
DHA-FFA free nonesterified form docosahexaenoic acid
DSM-IV Diagnostic and Statistical Manual of Mental Disorders, fourth edition
EPA eicosapentaenoic acid
FABPs fatty acid binding proteins
HDRS Hamilton depression rating scale
hs-CRP C-reactive protein
HVLT-R Hopkins verbal learning test–revised
iPLA2 cytosolic calcium-independent phospholipase A2
LA linoleic acid
LXA4 lipoxin A4
MADRS Montgomery–Åsberg depression rating scale
MMSE mini-mental state examination
MUFAs monounsaturated fatty acids
NPI Neuropsychiatric Inventory
NTB neuropsychological test battery
PD Parkinson’s disease
PKC protein kinase C
PLA2 phospholipase A2
PUFAs omega-3 polyunsaturated fatty acids
sPLA2 secretory phospholipase A2
RvD1 resolvin D1
TAC total antioxidant capacity
UPDRS unified Parkinson’s disease rating scale